-
Symbol
-
BDTX on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock
-
Latest Disclosed Ownership
-
2.73M shares
-
Security Ownership
-
4.8%
BB Biotech AG ownership in Black Diamond Therapeutics, Inc. Common Stock (BDTX)
2025-03-21 - BB Biotech AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.73M shares of Black Diamond Therapeutics, Inc. Common Stock (BDTX).
This represents 4.8% percent ownership of the company.
In their previous filing dated 2025-02-14, BB BIOTECH AG had reported owning 8.52M shares, indicating a decrease of -67.9% percent.